Page 87 - GTM-3-2
P. 87

Global Translational Medicine                                     Neuropathic pain after 23-gauge sclerotomy




            Table 1. Prevalence and intensity of eye symptoms, patient‑reported pain score, and other symptoms before and after surgery
            Symptoms                      No symptoms   Mild     Moderate   d  Severe   e  Mean score   P‑value
                                                           c
                                          n (%)         n (%)    n (%)       n (%)     (mean±SD)   (pre and post)
            Eye pain
             Pre-operative a              56 (74.6)     11 (14.7)  3 (4)     5 (6.7)    1.12±2.50     0.257
             Post-operative b             50 (66.7)     13 (17.3)  8 (10.7)  4 (5.3)    1.34±2.55
            Photophobia
             Pre-operative                54 (72)       10 (13.3)  4 (5.3)   7 (9.4)    1.42±2.97     0.816
             Post-operative               52 (69.3)     10 (13.3)  6 (8)     7 (9.4)    1.45±2.76
            Eye irritation and foreign body sensation
             Pre-operative                48 (64)       16 (21.3)  5 (6.7)   6 (8)      1.52±2.65     0.967
             Post-operative               49 (65.3)     15 (20)  4 (5.3)     7 (9.4)    1.52±2.75
            Tearing
             Pre-operative                53 (70.7)     10 (13.3)  8 (10.7)  4 (5.3)    1.30±2.47     0.637
             Post-operative               53 (70.7)     10 (13.3)  6 (8)     6 (8)      1.33±2.53
            Deep head and face pain
             Pre-operative                60 (80)       4 (5.3)  3 (4)       8 (10.7)   1.30±3.03     0.930
             Post-operative               60 (80)       3 (4)    4 (5.3)     8 (10.7)   1.26±2.90
            Facial numbness
             Pre-operative                65 (86.7)     0        0           10 (13.3)  0.13±1.15     0.785
             Post-operative               55 (73.3)     10 (13.3)  0         10 (13.3)  0.17±1.20
            Notes:  Pre-operative: Before the surgery;  Post-operative: Two months after the surgery. Eye symptoms:  Mild=1 – 3;  Moderate=4 – 6;  Severe=7 – 10.
                                                                                                 e
                                       b
                                                                                      d
                 a
                                                                              c
            Data analyzed with paired t-test or Wilcoxon test based on data normality.
            Table 2. Scores of quality of life at baseline and 2 months after surgery
            Disturbance in items of quality of life Pre‑operative mean score (0 – 10) ± SD (range)  Post‑operative mean score  (0 – 10) ± SD  P‑value
            General activity          0.48±1.67 (0 – 10)                        0.45±1.81 (0 – 10)     0.833
            Mood                      0.96±2.29 (0 – 10)                        0.77±2.31 (0 – 10)     0.369
            Walking ability           0.22±0.86 (0 – 6)                         0.21±1.22 (0 – 10)     0.832
            Normal daily work         0.49±1.64 (0 – 10)                        0.46±1.79 (0 – 10)     0.789
            Relationship              0.61±1.82 (0 – 10)                        0.50±2.00 (0 – 10)     0.634
            Sleep                     0.60±1.77 (0 – 10)                        0.54±1.98 (0 – 10)     0.654
            Enjoyment of life         0.81±2.12 (0 – 10)                        0.58±2.06 (0 – 10)     0.377
            Note: Data analyzed with paired t-test or Wilcoxon test based on data normality.

            Table 3. Association of pre‑operative factors with post‑operative analgesic use
            Pre‑operative variables       Post‑operative analgesic use     Odds ratio (95% CI)         P‑value
                                       No analgesic       Analgesic
            Eye pain                    0.81±2.09         2.62±3.69        1.24 (1.02 – 1.51), B=0.219  0.030
            Photophobia                 0.82±2.00         4.31±4.80        1.35 (1.12 – 1.62), B=0.30   0.001
            Foreign body sensation      1.29±2.49         2.62±3.18        1.17 (0.96 – 1.42)           0.112
            Tearing                     1.23±2.49         1.69±2.46        1.07 (0.85 – 1.33)           0.537
            Face pain                   0.77±2.32         3.85±4.56        1.28 (1.08 – 1.52), B=0.253  0.003
            Note: Data analyzed with linear regression model.



            Volume 3 Issue 2 (2024)                         5                               doi: 10.36922/gtm.1770
   82   83   84   85   86   87   88   89   90   91   92